ARCHIVES

Moertel Criticizes Janssen Over Levamisole Price, Delivers Final Report On Intergroup Adjuvant Trial

This article is from The Cancer Letter archive.

Vol. 18 No. 24 | June 12, 1992

Download PDF Visit The Full Archive

Related Articles

5-FU/Levamisole A community Success Story; Trials With Untreated Control Revised Or Dropped

October 13, 1989

House Preserves Funds For Space Station; Cancer Societies Reiterate Support For $170 Million Increase For NCI

August 7, 1992

Rauscher Labels With Congress, Says NCI Needs More Money

May 2, 1975

NIEHS, Five Grantees Form Toxicogenomics Group.

November 16, 2001

NCI Evaluating PDQ Evaluation

September 1, 1989

Fox Chase Cancer Center plans $1 billion expansion that would double its size.

October 22, 2004